| Net Loss per Share |
Net Loss per Share Diluted net loss per share is the same as basic net loss per share for all periods presented because the effects of potentially dilutive items were anti-dilutive, given the Company’s net loss. The following securities have been excluded from the calculation of weighted-average shares of common stock outstanding because the effect is anti-dilutive for each of the periods indicated. | | | | | | | | | | | | | | Three and Six Months Ended June 30, | | | 2024 | | 2023 | | | | | | Stock options | 100,058 | | | 161,760 | | | Restricted stock units | 88,226 | | | 212,283 | | | Performance restricted stock units | 77,112 | | | 87,485 | | | Shares related to convertible senior notes | 992,556 | | | 992,556 | | Total antidilutive securities (1) | 1,257,952 | | | 1,454,084 | |
| | | | | | | | | | | | | | | | (1) | | Amounts have been adjusted to reflect the Reverse Stock Split that became effective on June 13, 2024. Refer to Note 2 for further information about the Reverse Stock Split. |
The following table presents the calculation of the Company’s basic and diluted net loss per share for each of the periods indicated. | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | 2024 | | 2023 | | 2024 | | 2023 | | | | | | | | | | Numerator (in thousands): | | | | | | | | | Net loss | $ | (452,440) | | | $ | (173,654) | | | $ | (507,089) | | | $ | (227,716) | | | Denominator: | | | | | | | | Weighted-average shares of common stock outstanding, basic and diluted (1) | 2,804,924 | | | 2,685,645 | | | 2,793,262 | | | 2,664,889 | | Net loss per share, basic and diluted (1) | $ | (161.30) | | | $ | (64.66) | | | $ | (181.54) | | | $ | (85.45) | |
| | | | | | | | | | | | | | | | (1) | | Amounts have been adjusted to reflect the Reverse Stock Split that became effective on June 13, 2024. Refer to Note 2 for further information about the Reverse Stock Split. |
|